PDF herunterladen
Drug Res (Stuttg) 2017; 67(12): 688-697
DOI: 10.1055/s-0043-109565
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Characterisation and Safety of Intraperitoneal Perioperative Administration of Antibacterial Agents: A Systematic Review

Siv Fonnes
1   Centre for Perioperative Optimisation, Department of Surgery, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark
,
Barbara Juliane Holzknecht
2   Department of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark
,
Magnus Arpi
2   Department of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark
,
Jacob Rosenberg
1   Centre for Perioperative Optimisation, Department of Surgery, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 31. Januar 2017

accepted 21. April 2017

Publikationsdatum:
28. August 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Background Intraperitoneal drug administration applies treatment at the site of diseases with gynaecological, urological, or gastrointestinal origin. The objective of this systematic review was to investigate perioperative intraperitoneal administration of antibacterial agents to characterise the drugs used and their safety profile.

Methods A protocol was registered at PROSPERO (CRD42016038956). A systematic review was conducted and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A search was performed in PubMed and EMBASE on the 22nd of April 2016. The inclusion criteria were original articles involving at least 5 patients where antibacterial agents were administered intraperitoneally during or after abdominal surgery as prophylaxis or treatment of infection. Languages were limited to English, German, Danish, Norwegian, or Swedish articles.

Results 79 studies were included which used a total of 12 different antibacterial classes. Aminoglycosides, 1st and 2nd generation cephalosporins, tetracyclines, and penicillins were most commonly administered intraperitoneally during or after surgery. The antibacterial agent was usually administered intraperitoneally as monotherapy. However, some studies administered combination regimens with heparin or with another antibacterial agent. The most frequent combination was aminoglycosides and lincosamides. In total, 43% of studies lacked information regarding adverse events. The most frequently reported adverse event was discomfort or pain during administration, especially with use of oxytetracycline.

Conclusion At least 12 different classes of antibacterial agents have been administered intraperitoneally during or after surgery as prophylaxis or treatment of intraabdominal infections. Intraperitoneal administration seems safe although use of oxytetracycline may cause discomfort or pain.

Key words

antibacterial drugs - drug delivery - clinical trials

Supporting Information

    Supporting Information for this article is available online at http://www.thieme-connect.de/products
  • Supporting Information
 

  • References

  • 1 Ballinger AE, Palmer SC, Wiggins KJ. et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev 2014; 4: CD005284
    PubMedGoogle Scholar
  • 2 Sauven P, Playforth MJ, Smith GM. et al. Single-dose antibiotic prophylaxis of abdominal surgical wound infection: A trial of preoperative latamoxef against peroperative tetracycline lavage. J R Soc Med 1986; 79: 137-141
    CrossrefPubMedGoogle Scholar
  • 3 Long WH, Rudd EG, Dillon MB. Intrauterine irrigation with cefamandole nafate solution at cesarean section: A preliminary report. Am J Obstet Gynecol 1980; 138: 755-758
    CrossrefPubMedGoogle Scholar
  • 4 Kahokehr A, Sammour T, Soop M. et al. Intraperitoneal use of local anesthetic in laparoscopic cholecystectomy: Systematic review and metaanalysis of randomized controlled trials. J Hepatobiliary Pancreat Sci 2010; 17: 637-656
    CrossrefPubMedGoogle Scholar
  • 5 Marks JL, Ata B, Tulandi T. Systematic review and metaanalysis of intraperitoneal instillation of local anesthetics for reduction of pain after gynecologic laparoscopy. J Minim Invasive Gynecol 2012; 19: 545-553
    CrossrefPubMedGoogle Scholar
  • 6 Jaaback K, Johnson N, Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2016; 1: CD005340
    PubMedGoogle Scholar
  • 7 van Dijk PR, Logtenberg SJ, Gans RO. et al. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia. Clin Endocrinol 2014; 81: 488-497
    CrossrefPubMedGoogle Scholar
  • 8 Spaan N, Teplova A, Stam G. et al. Systematic review: Continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus. Acta Diabetol 2014; 51: 339-351
    CrossrefPubMedGoogle Scholar
  • 9 Wiesholzer M, Pichler P, Reznicek G. et al. An open, randomized, single-center, crossover pharmacokinetic study of meropenem after intraperitoneal and intravenous administration in patients receiving automated peritoneal dialysis. Antimicrob Agents Chemother 2016; 60: 2790-2797
    CrossrefPubMedGoogle Scholar
  • 10 Tobudic S, Matzneller P, Stoiser B. et al. Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis. Antimicrob Agents Chemother 2012; 56: 3992-3995
    CrossrefPubMedGoogle Scholar
  • 11 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535
    CrossrefPubMedGoogle Scholar
  • 12 PROSPERO. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID = CRD42016038956 (last accessed 05-01-2017)
    PubMed
  • 13 World Health Organization. http://www.whocc.no/atc_ddd_index/(last accessed 05-01-2017)
    PubMed
  • 14 The Cochrane Collaboration. http://handbook.cochrane.org/chapter_8/table_8_5_d_criteria_for_judging_risk_of_bias_in_the_risk_of.htm (last assessed 05-01-2017)
    PubMed
  • 15 Wells GA, Shea B, O’Connell D et al. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (last accessed 05-01-2017)
    PubMed
  • 16 Ruiz-Tovar J, Llavero C, Gamallo C. et al. Effect of peritoneal lavage with clindamycin-gentamicin solution during elective colorectal cancer surgery on the oncologic outcome. Surg Infect 2016; 17: 65-70
    CrossrefPubMedGoogle Scholar
  • 17 Hesami MA, Alipour H, Nikoupour Daylami H. et al. Irrigation of abdomen with imipenem solution decreases surgical site infections in patients with perforated appendicitis: A randomized clinical trial. Iran Red Crescent Med J 2014; 16: e12732
    PubMedGoogle Scholar
  • 18 Ruiz-Tovar J, Santos J, Arroyo A. et al. Effect of peritoneal lavage with clindamycin-gentamicin solution on infections after elective colorectal cancer surgery. J Am Coll Surg 2012; 214: 202-207
    CrossrefPubMedGoogle Scholar
  • 19 Parcells JP, Mileski JP, Gnagy FT. et al. Using antimicrobial solution for irrigation in appendicitis to lower surgical site infection rates. Am J Surg 2009; 198: 875-880
    CrossrefPubMedGoogle Scholar
  • 20 Schneider A, Sack U, Rothe K. et al. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. Pediatr Surg Int 2005; 21: 445-448
    CrossrefPubMedGoogle Scholar
  • 21 Görtz G. Local antiseptic and anti-endotoxin measures in intra-abdominal infections. Langenbecks Arch Für Chir 1997; 382: S37-S41
    PubMedGoogle Scholar
  • 22 Saha SK. Efficacy of metronidazole lavage in treatment of intraperitoneal sepsis. A prospective study. Dig Dis Sci 1996; 41: 1313-1318
    CrossrefPubMedGoogle Scholar
  • 23 Yelon JA, Green JD, Evans JT. Efficacy of an intraperitoneal antibiotic to reduce the incidence of infection in the trauma patient: A prospective, randomized study. J Am Coll Surg 1996; 182: 509-514
    PubMedGoogle Scholar
  • 24 Quendt J, Blank I, Seidel W. Peritoneal and subcutaneous administration of cefazolin as perioperative antibiotic prophylaxis in colorectal operations. Prospective randomized comparative study of 200 patients. Langenbecks Arch Für Chir 1996; 381: 318-322
    PubMedGoogle Scholar
  • 25 Magann EF, Dodson MK, Ray MA. et al. Preoperative skin preparation and intraoperative pelvic irrigation: Impact on post-cesarean endometritis and wound infection. Obstet Gynecol 1993; 81: 922-925
    PubMedGoogle Scholar
  • 26 Billing A, Fröhlich D, Ruckdeschel G. The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis. Langenbecks Arch Für Chir 1992; 377: 180-185
    PubMedGoogle Scholar
  • 27 Hancock BD. Audit of major colorectal and biliary surgery to reduce rates of wound infection. BMJ 1990; 301: 911-912
    CrossrefPubMedGoogle Scholar
  • 28 El-Sefi TA, El-Awady HM, Shehata MI. et al. Systemic plus local metronidazole and cephazolin in complicated appendicitis: A prospective controlled trial. J R Coll Surg Edinb 1989; 34: 13-16
    PubMedGoogle Scholar
  • 29 Salvati EP, Rubin RJ, Eisenstat TE. et al. Value of subcutaneous and intraperitoneal antibiotics in reducing infection in clean contaminated operations of the colon. Surg Gynecol Obstet 1988; 167: 315-318
    PubMedGoogle Scholar
  • 30 Greig J, Morran C, Gunn R. et al. Wound sepsis after colorectal surgery: the effect of cefotetan lavage. Chemioterapia 1987; 6: 595-596
    PubMedGoogle Scholar
  • 31 Krukowski ZH, Al-Sayer HM, Reid TM. et al. Effect of topical and systemic antibiotics on bacterial growth kinesis in generalized peritonitis in man. Br J Surg 1987; 74: 303-306
    CrossrefPubMedGoogle Scholar
  • 32 O’Brien PE, Tait N, Bushell M. Management of diffuse peritonitis by prolonged postoperative peritoneal lavage. Aust N Z J Surg 1987; 57: 181-184
    CrossrefPubMedGoogle Scholar
  • 33 Krukowski ZH, Koruth NM, Matheson NA. Antibiotic lavage in emergency surgery for peritoneal sepsis. J R Coll Surg Edinb 1986; 31: 1-6
    PubMedGoogle Scholar
  • 34 Krukowski ZH, Stewart MP, Alsayer HM. et al. Infection after abdominal surgery: five year prospective study. Br Med J (Clin Res Ed) 1984; 288: 278-280
    CrossrefPubMedGoogle Scholar
  • 35 Krukowski ZH, Matheson NA. The management of peritoneal and parietal contamination in abdominal surgery. Br J Surg 1983; 70: 440-441
    CrossrefPubMedGoogle Scholar
  • 36 Silverman SH, Ambrose NS, Youngs DJ. et al. The effect of peritoneal lavage with tetracycline solution on postoperative infection. A prospective, randomized, clinical trial. Dis Colon Rectum 1986; 29: 165-169
    CrossrefPubMedGoogle Scholar
  • 37 Kellum RB, Roberts WE, Harris JB. et al. Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. J Reprod Med 1985; 30: 527-529
    PubMedGoogle Scholar
  • 38 Saha SK. Peritoneal lavage with metronidazole. Surg Gynecol Obstet 1985; 160: 335-338
    PubMedGoogle Scholar
  • 39 Freischlag J, McGrattan M, Busuttil RW. Topical versus systemic cephalosporin administration in elective biliary operations. Surgery 1984; 96: 686-693
    PubMedGoogle Scholar
  • 40 Nelson KJ, Gallup DG, Gibbs R. et al. Intraoperative antibiotic irrigation as prophylaxis in abdominal hysterectomy: A preliminary report. South Med J 1984; 77: 700-702
    CrossrefPubMedGoogle Scholar
  • 41 Orr JD. Antibiotic peritoneal lavage in childhood appendicitis. J R Coll Surg Edinb 1984; 29: 307-309
    PubMedGoogle Scholar
  • 42 Flaherty JF, Boswell GW, Winkel CA. et al. Pharmacokinetics of cefoxitin in patients at term gestation: Lavage versus intravenous administration. Am J Obstet Gynecol 1983; 146: 760-766
    CrossrefPubMedGoogle Scholar
  • 43 Lord JW, LaRaja RD, Daliana M. et al. Prophylactic antibiotic wound irrigation in gastric, biliary, and colonic surgery. Am J Surg 1983; 145: 209-212
    CrossrefPubMedGoogle Scholar
  • 44 Udén P, Eskilsson P, Brunes L. et al. A clinical evaluation of postoperative peritoneal lavage in the treatment of perforated appendicitis. Br J Surg 1983; 70: 348-349
    CrossrefPubMedGoogle Scholar
  • 45 Washington BC, Villalba MR, Lauter CB. et al. Cefamandole-erythromycin-heparin peritoneal irrigation: An adjunct to the surgical treatment of diffuse bacterial peritonitis. Surgery 1983; 94: 576-581
    PubMedGoogle Scholar
  • 46 Duff P, Gibbs RS, Jorgensen JH. et al. The pharmacokinetics of prophylactic antibiotics administered by intraoperative irrigation at the time of cesarean section. Obstet Gynecol 1982; 60: 409-412
    PubMedGoogle Scholar
  • 47 Rudd EG, Cobey EA, Long WH. et al. Prevention of endomyometritis using antibiotic irrigation during cesarean section. Obstet Gynecol 1982; 60: 413-416
    PubMedGoogle Scholar
  • 48 Constantinides C, Pappis C, Giamarellou H. et al. Intraperitoneal gentamicin in appendiceal peritonitis in children: A pharmacokinetic study. Zeitschrift Für Kinderchirurgie 1981; 32: 315-320
    PubMedGoogle Scholar
  • 49 Roland M, Bergan T, Jakobsen A. et al. Effect of metronidazole and ampicillin on patients with gangrenous or perforated appendicitis. A comparative study. Scand J Infect Dis Suppl 1981; 26: 92-95
    PubMedGoogle Scholar
  • 50 Duyzings JW, Wesdorp RI, Lemmens HA. et al. Results of therapy combining peritoneal lavage and local application of antibiotics in 250 patients with acute perforating appendicitis. Der Chir 1980; 51: 519-523
    PubMedGoogle Scholar
  • 51 Moukhtar M, Romney S. Continuous intraperitoneal antibiotic lavage in the management of purulent sepsis of the pelvis. Surg Gynecol Obstet 1980; 150: 548-550
    PubMedGoogle Scholar
  • 52 Olesen A, Jørgensen F, Bilde T. et al. Peritoneal lavage in diffuse peritonitis originating from perforated appendix. Ugeskr Laeger 1980; 142: 1415-1418
    PubMedGoogle Scholar
  • 53 Shweni PM, Pitsoe SB, Mokgokong ET. Continuous antibiotic peritoneal lavage compared with simple drainage for severe intraperitoneal sepsis of gynaecological and obstetric origin. South African Med J 1980; 57: 117-120
    PubMedGoogle Scholar
  • 54 Ericsson CD, Duke JH, Pickering LK. et al. Systemic absorption of bacitracin after peritoneal lavage. Am J Surg 1979; 137: 65-67
    CrossrefPubMedGoogle Scholar
  • 55 Stephen M, Loewenthal J. Continuing peritoneal lavage in high-risk peritonitis. Surgery 1979; 85: 603-606
    PubMedGoogle Scholar
  • 56 Ericsson CD, Duke JH, Pickering LK. Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infections. Ann Surg 1978; 188: 66-70
    CrossrefPubMedGoogle Scholar
  • 57 Raine PA, Courtis GR, Fowler R. et al. The intraperitoneal use of cephazolin. J Surg Res 1978; 25: 232-235
    CrossrefPubMedGoogle Scholar
  • 58 Stewart DJ, Matheson NA. Peritoneal lavage in appendicular peritonitis. Br J Surg 1978; 65: 54-56
    CrossrefPubMedGoogle Scholar
  • 59 Atkins RC, Scott DF, Holdsworth SR. et al. Prolonged antibiotic peritoneal lavage in the management of gross generalized peritonitis. Med J Aust 1976; 1: 954-956
    CrossrefPubMedGoogle Scholar
  • 60 Gjessing J, Tomlin PJ. Acute appendicitis and continuous peritoneal lavage. Anaesth Intensive Care 1976; 4: 347-350
    CrossrefPubMedGoogle Scholar
  • 61 Haffner JF, Eng J, Løtveit T. et al. Peritoneal lavage with doxycycline in acute diffuse peritonitis. Ann Chir Gynaecol 1976; 65: 22-26
    PubMedGoogle Scholar
  • 62 Matolo NM, Cohen SE, Wolfman EF. Effects of antibiotics on prevention of infection in contaminated abdominal operations. Am Surg 1976; 42: 123-127
    PubMedGoogle Scholar
  • 63 Raine PA, Young DG, McAllister TA. et al. Tobramycin in pediatric use. J Infect Dis 1976; 134 Suppl: S165-S169
    CrossrefPubMedGoogle Scholar
  • 64 Sherman JO, Luck SR, Borger JA. Irrigation of the peritoneal cavity for appendicitis in children: A double-blind study. J Pediatr Surg 1976; 11: 371-374
    CrossrefPubMedGoogle Scholar
  • 65 Smith EB. A rationale for intraperitoneally administered antibiotic therapy. Surg Gynecol Obstet 1976; 143: 561-564
    PubMedGoogle Scholar
  • 66 Bhushan C, Mital VK, Elhence IP. Continuous postoperative peritoneal lavage in diffuse peritonitis using balanced saline antibiotic solution. Int Surg 1975; 60: 526-528
    PubMedGoogle Scholar
  • 67 Fowler R. A controlled trial of intraperitoneal cephaloridine administration in peritonitis. J Pediatr Surg 1975; 10: 43-50
    CrossrefPubMedGoogle Scholar
  • 68 Hunt JA, Rivlin ME, Clarebout HJ. Antibiotic peritoneal lavage in severe peritonitis. A preliminary assessment. South African Med J 1975; 49: 233-238
    PubMedGoogle Scholar
  • 69 Nelson JL, Kuzman JH, Cohn I. Intraperitoneal lavage and kanamycin for the contaminated abdomen. Surg Clin North Am 1975; 55: 1391-1395
    CrossrefPubMedGoogle Scholar
  • 70 Normann E, Korvald E, Løtveit T. Perforated appendicitis – lavage or drainage?. Ann Chir Gynaecol Fenn 1975; 64: 195-197
    PubMedGoogle Scholar
  • 71 Aune S, Normann E. Diffuse peritonitis treated with continuous peritoneal lavage. Acta Chir Scand 1970; 136: 401-404
    PubMedGoogle Scholar
  • 72 Ciccone PN, Malament M, Bellingham C. Surgical wound irrigation. Kanamycin sulfate versus saline. Urology 1974; 3: 63-66
    CrossrefPubMedGoogle Scholar
  • 73 Kiene S, Troeger H. Intraperitoneal drainage with antibiotics in diffuse peritonitis 2. Zentralbl Chir 1974; 99: 833-840
    PubMedGoogle Scholar
  • 74 Peloso OA, Floyd VT, Wilkinson LH. Treatment of peritonitis with continuous postoperative peritoneal lavage using cephalothin. Am J Surg 1973; 126: 742-747
    CrossrefPubMedGoogle Scholar
  • 75 Smith EB. Adjuvant therapy of generalized peritonitis with intraperitoneally administered cephalothin. Surg Gynecol Obstet 1973; 136: 441-443
    PubMedGoogle Scholar
  • 76 Smith EB. Intraperitoneal cephalothin as adjuvant therapy in peritonitis. J Natl Med Assoc 1972; 64: 109-111
    PubMedGoogle Scholar
  • 77 Pissiotis CA, Nichols RL, Condon RE. Absorption and excretion of intraperitoneally administered kanamycin sulfate. Surg Gynecol Obstet 1972; 134: 995-998
    PubMedGoogle Scholar
  • 78 Rambo WM. Irrigation of the peritoneal cavity with cephalothin. Am J Surg 1972; 123: 192-195
    CrossrefPubMedGoogle Scholar
  • 79 DiVincenti FC, Cohn I. Prolonged administration of intraperitoneal kanamycin in the treatment of peritonitis. Am Surg 1971; 37: 177-180
    PubMedGoogle Scholar
  • 80 DiVincenti FC, Cohn I. Intraperitoneal kanamycin in advanced peritonitis. A preliminary report. Am J Surg 1966; 111: 147-153
    CrossrefPubMedGoogle Scholar
  • 81 Normann E, Aune S. Absorption of ampicillin from the peritoneal cavity. In patients with diffuse peritonitis. Arch Surg 1971; 102: 469-470
    CrossrefPubMedGoogle Scholar
  • 82 McKenna JP, Currie DJ, MacDonald JA. et al. The use of continuous postoperative peritoneal lavage in the management of diffuse peritonitis. Surg Gynecol Obstet 1970; 130: 254-258
    PubMedGoogle Scholar
  • 83 McMullan MH, Barnett WO. The clinical use of intraperitoneal cephalothin. Surgery 1970; 67: 432-436
    PubMedGoogle Scholar
  • 84 Goldenberg IS, Bevin AG, Graham AJ. An evaluation of intraperitoneal sodium cephalothin. Conn Med 1967; 31: 504-506
    PubMedGoogle Scholar
  • 85 Noon GP, Beall AC, Jordan GL. et al. Clinical evaluation of peritoneal irrigation with antibiotic solution. Surgery 1967; 62: 73-78
    PubMedGoogle Scholar
  • 86 Aune S. Intraperitoneal nebacetin-hydrocortisone in acute peritonitis caused by appendicitis. A controlled clinical trial. J Oslo City Hosp 1965; 15: 183-197
    PubMedGoogle Scholar
  • 87 Rickles JA. Nitrofurantoin sodium as a systemic antibacterial in surgical patients. Part II: prophylactic usage. J Int Coll Surg 1965; 43: 603-610
    PubMedGoogle Scholar
  • 88 Cohn I, Cotlar AM, Richard L. Intraperitoneal kanamycin – clinical experience. Am Surg 1963; 29: 756-760
    PubMedGoogle Scholar
  • 89 Cohn I, Cotlar AM. Intraperitoneal kanamycin. Ann Surg 1962; 155: 532-537
    CrossrefPubMedGoogle Scholar
  • 90 Köves I, Rónay P, Csengödy J. Treatment of diffuse purulent peritonitis by the administration of antibiotics in the abdominal cavity. Zentralblatt Für Chir 1960; 85: 647-654
    PubMedGoogle Scholar
  • 91 Adwan KO, Lumpkin FE, Stirman JA. et al. Treatment of peritonitis of appendical origin with and without intraperitoneal terramycin. Am Surg 1958; 24: 452-457
    PubMedGoogle Scholar
  • 92 Greene HG. Intraperitoneal neomycin in the treatment of acute bacterial peritonitis. Surg Gynecol Obstet 1958; 107: 169-172
    PubMedGoogle Scholar
  • 93 Prigot A, Shildlovsky BA, Cambell EA. Intraperitoneal use of kanamycin as an adjunct in the therapy of established peritonitis and peritoneal contamination. Ann N Y Acad Sci 1958; 76: 204-211
    PubMedGoogle Scholar
  • 94 Diamond JJ, Impink RR. Intraperitoneal administration of terramycin in the treatment of generalized peritonitis. Am J Surg 1957; 93: 449-452
    CrossrefPubMedGoogle Scholar
  • 95 Schatten WE. Intraperitoneal antibiotic administration in the treatment of acute bacterial peritonitis. Surg Gynecol Obstet 1956; 102: 339-346
    PubMedGoogle Scholar
  • 96 Schatten WE, Des Prez JD, Cline TN. et al. Intraperitoneal administration of terramycin in the treatment of acute bacterial peritonitis. Surg Forum 1953; 4: 630-637
    PubMedGoogle Scholar
  • 97 Avecilla M. Intraperitoneal neomycin as an adjunct in the surgical management of generalized peritonitis; report of five cases. Harlem Hosp Bull 1955; 8: 46-51
    PubMedGoogle Scholar
  • 98 Högman CF, Schager N. Intraperitoneal administration of tetracycline in man; preliminary report of concentration levels in peritoneal fluid and serum. Acta Chir Scand 1955; 108: 439-442
    PubMedGoogle Scholar
  • 99 Young JP, Cole WH. Intraperitoneal administration of succinylsulfathiazole and phthalylsulfathiazole; their use in the prophylaxis and treatment of peritonitis. Arch Surg 1946; 53: 182-189
    CrossrefPubMedGoogle Scholar
  • 100 Hasper D, Schefold JC, Baumgart DC. Management of severe abdominal infections. Recent Pat Antiinfect Drug Discov 2009; 4: 57-65
    CrossrefPubMedGoogle Scholar
  • 101 Krobot K, Yin D, Zhang Q. et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004; 23: 682-687
    PubMedGoogle Scholar
  • 102 Eckmann C, Dryden M, Montravers P. et al. Antimicrobial treatment of “complicated” intra-abdominal infections and the new IDSA guidelines – a commentary and an alternative European approach according to clinical definitions. Eur J Med Res 2011; 16: 115-126
    CrossrefPubMedGoogle Scholar
  • 103 Moher D, Hopewell S, Schulz KF. et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010; 63: e1-e37
    CrossrefPubMedGoogle Scholar
  • 104 Kanji S, Hayes M, Ling A. et al. Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement. Clin Pharmacokinet 2015; 54: 783-795
    CrossrefPubMedGoogle Scholar
  • 105 Prakash J, Tripathi K, Singh M. Complications of intermittent peritoneal dialysis. J Assoc Physicians India 1990; 38: 906-908
    PubMedGoogle Scholar
  • 106 Kawanishi K, Honda K, Tsukada M. et al. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int 2013; 33: 242-251
    CrossrefPubMedGoogle Scholar
  • 107 Vardhan A, Zweers MM, Gokal R. et al. A solutions portfolio approach in peritoneal dialysis. Kidney Int 2003; 64 (Suppl. 88) S114-S123
    CrossrefPubMedGoogle Scholar
  • 108 Rippe B, Simonsen O, Wieslander A. et al. Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1997; 17: 27-34
    PubMedGoogle Scholar
  • 109 Mactier RA, Sprosen TS, Gokal R. et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998; 53: 1061-1067
    CrossrefPubMedGoogle Scholar
  • 110 Yamamoto T, Sakakura T, Yamakawa M. et al. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60: 324-329
    CrossrefPubMedGoogle Scholar
  • 111 Pedersen FB, Ryttov N, Deleuran P. et al. Acetate versus lactate in peritoneal dialysis solutions. Nephron 1985; 39: 55-58
    CrossrefPubMedGoogle Scholar
  • 112 Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int 1994; 14 (Suppl. 03) S21-S28
    CrossrefPubMedGoogle Scholar
  • 113 Williams JD, Craig KJ, Topley N. et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
    PubMedGoogle Scholar
  • 114 Ayuzawa N, Ishibashi Y, Takazawa Y. et al. Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: Recent clinical practice in Japan. Perit Dial Int 2012; 32: 159-167
    CrossrefPubMedGoogle Scholar
  • 115 Tawada M, Ito Y, Hamada C. et al. Vascular endothelial cell injury is an important factor in the development of encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients. PLoS One 2016; 11: e0154644
    CrossrefPubMedGoogle Scholar